Ted Natoli

Associate Director Of Data Science at Prologue Medicines

Ted Natoli is an experienced professional in data science and bioinformatics, currently serving as the Associate Director of Data Science at Prologue Medicines since September 2023, focusing on leveraging viral evolution for the development of biologic therapies. Prior to this role, Ted was the Associate Director of Bioinformatics at ImmuneID, leading a team to maximize data utility across various projects and implementing critical data processing pipelines. With a formidable background at the Broad Institute of MIT and Harvard as a Group Leader in Computational Biology, Ted managed teams and directed analysis strategies within significant cancer research initiatives. Earlier experiences include consulting roles and positions where Ted enhanced bioinformatics solutions and data analysis efficiencies in several organizations. Ted holds a Master's degree in Biotechnology with a concentration in Bioinformatics from Harvard Extension School and a Bachelor's degree in Biomedical Engineering from Boston University.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Prologue Medicines

1 followers

Prologue is designing powerful new medicines by unlocking the viral proteome. The company’s state-of-the-art DELVE™ Platform systematically identifies and evaluates viral proteins and their unique features for their potential to precisely regulate human physiology. By co-opting viral evolution, Prologue is expanding the functional boundaries of proteins encoded by the human genome to create new programmable medicines. Prologue was founded by Flagship Pioneering in 2021.


Employees

11-50

Links